Basic information
- CAS
5534-02-1- Standard SMILES
CCCC(=O)O[C@]1(C(=O)COC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C- InChIKey
VXOWJCTXWVWLLC-REGDIAEZSA-N- Molecular formula
- C29H39FO7
- Average molar mass
- 518.6 g/mol
- Monoisotopic mass
- 518.26798174
Overview
Betamethasone butyrate propionate is a corticosteroid hormone.
Names & identifiers
- Preferred name
- Betamethasone Butyrate Propionate
- IUPAC
- [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoate
- English name
- BETAMETHASONE BUTYRATE PROPIONATE
- Molecular formula
- C29H39FO7
- Molecular weight
- 518.61
Names & synonyms
Betamethasone butyrate propionate5534-02-1DTXSID702267150FH5AG9RWDTXCID902671RefChem:568009(11beta,16beta)-9-Fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)-21-(1-oxopropoxy)pregna-1,4-diene-3,20-dioneBetamethasone-17-butyrate-21-propionate[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoateBetamethasone butyrate propionate [JAN]Antebate (TN)Betamethasone butyrate propionate (JAN)
Show more names
SalexAntebateAnflavateBetamethasone 17-butyrate 21-propionate9-Fluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-butyrate 21-propionatePregna-1,4-diene-3,20-dione,9-fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)-21-(1-oxopropoxy)-,(11b,16b)-Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17-(1-oxobutoxy)-21-(1-oxopropoxy)-, (11β,16β)-
Properties
Computed structural properties
- XLogP
- 3.4
- Topological polar surface area
- 107 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 8
- Rotatable bonds
- 9
- Heavy atoms
- 37
- Formal charge
- 0
- Complexity
- 1,060
Experimental & physicochemical properties
DrugsPharmaceuticals -> Dermatologicals -> Corticosteroids, dermatological preparations
Physicochemical properties
- Melting point
- 152 ℃ · approximate 152℃
- Boiling point
- 613 · 613.0±55.0 °C(Predicted)
- Density
- 1.23 · 1.23±0.1 g/cm3(Predicted)
- storage temp.
- -20 °C · -20°C Freezer, Under inert atmosphere
- solubility
- Chloroform (Slightly), Dioxane (Slightly, Sonicated), Methanol (Slightly)
- form
- Solid
- pka
- 12.88 · 12.88±0.70(Predicted)
- color
- White to Off-White
- FDA UNII
- 50 FH5AG9RW · 50FH5AG9RW
- Symbol(GHS)
- 8 · GHS08
- Signal word
- Warning
- Hazard statements
- 373 · H373-H361-H362
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
GHS classification
GHS Classification
This chemical does not meet GHS hazard criteria for 50% (1 of 2) of reports.
Warning
H361 (50%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
P203, P260, P263, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Hazard Classes and CategoriesRepr. 2 (50%)
Safety data
- Signal word
- Warning
- Symbol(GHS)
- GHS08
- Hazard statements
- H373-H361-H362
- Precautionary statements
- P260-P314-P501-P201-P202-P281-P308+P313-P405-P501-P201-P260-P263-P264-P270-P308+P313
Chemistry & industry
Applications
DescriptionBetamethasone butyrate propionate (BBP) was introduced in Japan as a topical antiinflammatory agent. It is a synthetic corticosteroid with strong antiinflammatory activity at the site of inflammation but without topical or systemic side effects. On paper disk granuloma in rats, BBP was shown to have higher degree of dissociation between antiinflammation efficacy and systemic side effects than other agents in this class. Antipyretic/analgesic properties have also been reported.
UsesBetamethasone-17-butyrate-21-propionate are used in the treatment of vitiligo vulgaris with the combination therapy of topical steroid and vitamin D3 compound.
Suppliers19 total
艾吉析科技（上海）有限公司17717235263 · [email protected]
安耐吉化学&3A（安徽泽升科技有限公司）021-58432009 400-005-6266 · [email protected]
梯希爱（上海）化工贸易有限公司021-61109150 · [email protected]
武汉菲越生物科技有限公司027-87002654 15827563343 · [email protected]
InvivoChem中国13549236410 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
Xiamen AmoyChem Co., Ltd+86-86-5926051114 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
陕西缔都医药化工有限公司029-81024372 17792795018 · [email protected]
Related reactions
0 records
No reaction records under the current filter.
Compound notes
Loading…